A 76-year-old woman was admitted because of progressive asthenia. There was no lymphadenopathy or organomegaly, which was confirmed by computed tomography scan. Laboratory studies included lactate dehydrogenase, 20 681 IU/L (normal range, 208-378). Hemoglobin was 113 g/L (normal range, 117-161), platelets 70.0 × 109/L (normal range, 135-400) and white blood cell count was 42.5 × 109/L (normal range, 4.0-10.5). A manual cell count revealed 35% immature cells (panel A; May-Grünwald-Giemsa stain, original magnification ×1000). The bone marrow aspirate showed 77% atypical immature cells with hyperbasophilic cytoplasm and conspicuous vacuolization (main panel; May-Grünwald-Giemsa stain, original magnification ×1000). Immunophenotype was CD19+, CD20+, CD22+, CD10+dim, and CD38+hi. TdT was negative. Karyotype was 48-52,XX+1, del(1)(p13),del81)(q21), add(3)(q27),+5,+8, add(8)(q24), +14,t(14;18)(q32;q21), +20, −22, +2mar[16]/46,XX[4] (panel B). Fluorescence in situ hybridization analysis showed rearrangements of c-MYC (62%), BCL2 (40%), and BCL6 (48%) (panels C, D, and E, respectively; original magnification ×1000). A diagnosis of triple hit high-grade B-cell lymphoma (HGBCL) (leukemic phase) was established.
Within the current World Health Organization classification, 2 HGBCL subgroups are described: those with MYC and BCL2 and/or BCL6 (HGBCL double-hit/triple-hit) and the other who lack those rearrangements (HGBCL not otherwise specified). Most HGBCL DL/TL present with widespread disease. Cases without nodal involvement are rare. One-half of HGBCL cases present with Burkitt-like morphology but with less basophilia and absence of vacuolization. We here present a rare case of triple-hit HGBCL with only bone marrow and peripheral blood involvement and hyperbasophilic Burkitt-like morphology that highlights the complexity of diagnosis with immature-appearing lymphomas.
A 76-year-old woman was admitted because of progressive asthenia. There was no lymphadenopathy or organomegaly, which was confirmed by computed tomography scan. Laboratory studies included lactate dehydrogenase, 20 681 IU/L (normal range, 208-378). Hemoglobin was 113 g/L (normal range, 117-161), platelets 70.0 × 109/L (normal range, 135-400) and white blood cell count was 42.5 × 109/L (normal range, 4.0-10.5). A manual cell count revealed 35% immature cells (panel A; May-Grünwald-Giemsa stain, original magnification ×1000). The bone marrow aspirate showed 77% atypical immature cells with hyperbasophilic cytoplasm and conspicuous vacuolization (main panel; May-Grünwald-Giemsa stain, original magnification ×1000). Immunophenotype was CD19+, CD20+, CD22+, CD10+dim, and CD38+hi. TdT was negative. Karyotype was 48-52,XX+1, del(1)(p13),del81)(q21), add(3)(q27),+5,+8, add(8)(q24), +14,t(14;18)(q32;q21), +20, −22, +2mar[16]/46,XX[4] (panel B). Fluorescence in situ hybridization analysis showed rearrangements of c-MYC (62%), BCL2 (40%), and BCL6 (48%) (panels C, D, and E, respectively; original magnification ×1000). A diagnosis of triple hit high-grade B-cell lymphoma (HGBCL) (leukemic phase) was established.
Within the current World Health Organization classification, 2 HGBCL subgroups are described: those with MYC and BCL2 and/or BCL6 (HGBCL double-hit/triple-hit) and the other who lack those rearrangements (HGBCL not otherwise specified). Most HGBCL DL/TL present with widespread disease. Cases without nodal involvement are rare. One-half of HGBCL cases present with Burkitt-like morphology but with less basophilia and absence of vacuolization. We here present a rare case of triple-hit HGBCL with only bone marrow and peripheral blood involvement and hyperbasophilic Burkitt-like morphology that highlights the complexity of diagnosis with immature-appearing lymphomas.
For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit http://imagebank.hematology.org.
![A 76-year-old woman was admitted because of progressive asthenia. There was no lymphadenopathy or organomegaly, which was confirmed by computed tomography scan. Laboratory studies included lactate dehydrogenase, 20 681 IU/L (normal range, 208-378). Hemoglobin was 113 g/L (normal range, 117-161), platelets 70.0 × 109/L (normal range, 135-400) and white blood cell count was 42.5 × 109/L (normal range, 4.0-10.5). A manual cell count revealed 35% immature cells (panel A; May-Grünwald-Giemsa stain, original magnification ×1000). The bone marrow aspirate showed 77% atypical immature cells with hyperbasophilic cytoplasm and conspicuous vacuolization (main panel; May-Grünwald-Giemsa stain, original magnification ×1000). Immunophenotype was CD19+, CD20+, CD22+, CD10+dim, and CD38+hi. TdT was negative. Karyotype was 48-52,XX+1, del(1)(p13),del81)(q21), add(3)(q27),+5,+8, add(8)(q24), +14,t(14;18)(q32;q21), +20, −22, +2mar[16]/46,XX[4] (panel B). Fluorescence in situ hybridization analysis showed rearrangements of c-MYC (62%), BCL2 (40%), and BCL6 (48%) (panels C, D, and E, respectively; original magnification ×1000). A diagnosis of triple hit high-grade B-cell lymphoma (HGBCL) (leukemic phase) was established.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/136/10/10.1182_blood.2020007134/1/m_bloodbld2020007134f1.png?Expires=1769120507&Signature=jbe8cMXKngTQ3pZJvZ3uauxfe1UF8m7~Q7QvbF8yAdZn4MA9gho0YrhLLOz7j3QGZjsJ1-2kbcV3ZMDHO-0MY34fLUIbE3O2OzqfnGVfTGiP96fgmJYGdVYd69vn-QlPD~z-QM-2KiMaP~eDGyTJGWdjBdW6en0YcyilqVr4G-LRNP6NWK0Ci-0kR6btdG5V~92q-3YADLn31RJy6RoGtiarPc2si-UoPX6yI-rjnm9EPGiYST0ezPqJo07JasND9pevaumNXzQDcuvn~mjwEJHdVPL-BXLW48wW4CQsuUuiZ8vq1MfdsgPovW1-z5QcijrCi85rZUaj7q8EgewfSw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)